Norges Bank Personalis, Inc. Transaction History

Norges Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$7.56 - $14.3 $754,488 - $1.43 Million	-99,800 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$12.24 - $21.25 $1.22 Million - $2.12 Million	99,800 New	99,800 $1.42 Million
Q3 2021 Nov 14, 2022	BUY	$16.69 - $26.05 $1.67 Million - $2.6 Million	99,800 New	99,800 $1.92 Million
Q3 2021 Nov 05, 2021	SELL	$16.69 - $26.05 $3.22 Million - $5.03 Million	-192,900 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$18.15 - $27.75 $3.5 Million - $5.35 Million	192,900 New	192,900 $4.88 Million
Q3 2019 Nov 08, 2019	SELL	$14.16 - $25.34 $920,400 - $1.65 Million	-65,000 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$27.0 - $30.25 $1.76 Million - $1.97 Million	65,000 New	65,000 $1.77 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.